What is the analyst consensus rating for ANAB?

The analyst consensus rating for ANAB is "Buy" based on 13 analyst recommendations.

What is the average price target for ANAB?

The average 12-month price target for ANAB is $79.00, representing an upside of 31.5% from the current price of $60.08.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

AnaptysBio, Inc. (ANAB) Forecast: Analyst Ratings & Targets

Latest ANAB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Apr 28, 2026	David Risinger	Leerink Partners	Maintains	Buy	$66.00 → $85.00 +19.00 (28.8%)
Apr 22, 2026	Etzer Darout	Barclays	Maintains	Buy	$79.00 → $63.00 -16.00 (-20.3%)
Apr 21, 2026	Michael Yee	UBS	Maintains	Strong Buy	$90.00 → $60.00 -30.00 (-33.3%)
Apr 3, 2026	Anupam Rama	JP Morgan	Maintains	Buy	$69.00
Mar 31, 2026	David Nierengarten	Wedbush	Reiterates	Buy	$60.00 → $75.00 +15.00 (25.0%)
Mar 31, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$67.00 → $95.00 +28.00 (41.8%)
Mar 30, 2026	Emily Bodnar	HC Wainwright	Reiterates	Strong Buy	$66.00 → $66.00 +0.00 (0.0%)
Mar 17, 2026	Michael Yee	UBS	Maintains	Strong Buy	$70.00 → $90.00 +20.00 (28.6%)
Mar 12, 2026	Martin Fan	Wedbush	Maintains	Buy	$60.00 → $75.00 +15.00 (25.0%)
Mar 9, 2026	John Lee	Truist	Maintains	Hold	$36.00 → $50.00 +14.00 (38.9%)
Mar 5, 2026	Alex Thompson CFA	Stifel Nicolaus	Maintains	Buy	$56.00 → $85.00 +29.00 (51.8%)
Mar 5, 2026	Alex Thompson	Stifel	Maintains	Strong Buy	$56.00 → $85.00 +29.00 (51.8%)
Mar 4, 2026	Yatin Suneja	Guggenheim	Reiterates	Buy	$140.00
Mar 4, 2026	Emily Bodnar	HC Wainwright	Maintains	Strong Buy	$51.91 → $66.00 +14.09 (27.1%)
Mar 4, 2026	Etzer Darout	Barclays	Maintains	Buy	$78.00 → $79.00 +1.00 (1.3%)
Mar 3, 2026	Joseph Thome	TD Cowen	Maintains	Buy	-
Mar 3, 2026	Anupam Rama	JP Morgan	Maintains	Buy	-

David Risinger

Leerink Partners

BuyMaintains

$66.00 → $85.00

Apr 28

Etzer Darout

Barclays

BuyMaintains

$79.00 → $63.00

Apr 22

Michael Yee

UBS

Strong BuyMaintains

$90.00 → $60.00

Apr 21

Anupam Rama

JP Morgan

BuyMaintains

$69.00

Apr 3

David Nierengarten

Wedbush

BuyReiterates

$60.00 → $75.00

Mar 31

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$67.00 → $95.00

Mar 31

Emily Bodnar

HC Wainwright

Strong BuyReiterates

$66.00 → $66.00

Mar 30

Michael Yee

UBS

Strong BuyMaintains

$70.00 → $90.00

Mar 17

Martin Fan

Wedbush

BuyMaintains

$60.00 → $75.00

Mar 12

John Lee

Truist

HoldMaintains

$36.00 → $50.00

Mar 9

Alex Thompson CFA

Stifel Nicolaus

BuyMaintains

$56.00 → $85.00

Mar 5

Alex Thompson

Stifel

Strong BuyMaintains

$56.00 → $85.00

Mar 5

Yatin Suneja

Guggenheim

BuyReiterates

$140.00

Mar 4

Emily Bodnar

HC Wainwright

Strong BuyMaintains

$51.91 → $66.00

Mar 4

Etzer Darout

Barclays

BuyMaintains

$78.00 → $79.00

Mar 4

Joseph Thome

TD Cowen

BuyMaintains

Mar 3

Anupam Rama

JP Morgan

BuyMaintains

Mar 3

AnaptysBio, Inc. (ANAB) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest ANAB Analyst Ratings & Recommendations

Frequently Asked Questions